|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
175 Crossing Boulevard,Framingham,MA,US
|
|
Company Profile LFB USA, Inc. is a privately held biotechnology company in the Boston, Massachusetts area with headquarters and laboratories in Framingham, MA and production operations in Charlton, MA. LFB USA is a company within the LFB Group. LFB USA provides development, manufacturing and services to LFB S.A., its sister company rEVO Biologics, and other partners. One of the lead projects of LFB S.A. is the recombinant human Factor FVIIa (LR769) program. LFB USA is responsible for the upstream manufacturing of the recombinant protein and the Clinical and Regulatory aspects of the program. LR769 is currently being evaluated in a Phase 3 study in adults with congenital hemophilia A or B with inhibitors. LFB USA’s principal goal is to advance medical care by utilizing its proprietary technology to develop its own programs and assist its partners by providing a full range of services. LFB USA is currently looking for motivated scientific, business and healthcare professionals with an entrepreneurial spirit. For more information about LFB USA please visit www.lfb-usa.com Company Background LFB USA, Inc. was formed as a subsidiary of LFB Biotechnologies in April, 2014 as the result of a carve-out of rEVO Biologics, Inc.
|
LFB USA Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
50%
|
The widely used LFB USA email format is {first}.{last} (e.g. [email protected]) with 50% adoption across the company.
To contact LFB USA customer service number in your country click here to find.
Jose Antonio Moreno Toscano is the CEO of LFB USA. To contact Jose Antonio Moreno Toscano email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.